An influence of Treatment of Renal Anemia on Iron Dysregulation in patients with chronic kidney disease

Not Applicable

• Conditions: chronic kidney disease (CKD)

• Registration Number: JPRN-UMIN000004136
• Lead Sponsor: Hyogo College of Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-09-01
• Study Completion: 2011-06-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Not provided

Exclusion Criteria

malignant disease, blood disease, severe infection

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Anemia: RBC,Hb,Ht,reticulocytes etc. Iron metabolism: serum iron, TIBC, Tsat, ferritin,hepcidin,aminolevulinic acid,iron transporters etc.

Secondary Outcome Measures

Name	Time	Method
inflammation and oxidative stress: high-sensitivity-CRP,pentraxin,inflammatory cytokines (IL-6,TNF-alpha), malondialdehyde,8-OHdG etc. MBD: metabolism of Ca and P (PTH,FGF23,fetuinA),markers of bone metabolism (BMD etc.),markers of vasculopathy (pulse wave velocity etc.)